Article Text
Letter
Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema
Statistics from Altmetric.com
- triamcinolone acetonide
- diabetic retinopathy
- diabetic macular oedema
- diabetes mellitus
- intravitreal medication
Recent studies have suggested that intravitreal triamcinolone acetonide may be a treatment option for diffuse diabetic macular oedema.1 Since the duration of the effect of an intravitreal application of triamcinolone acetonide lasts between 4 weeks and up to 9 months,2,3 the purpose of this study was to evaluate the effect of a repeated intravitreal injection of triamcinolone acetonide.
Case reports
The clinical interventional case series study included four patients with diffuse diabetic macular oedema who consecutively received a second intravitreal injection of about 20 mg triamcinolone acetonide 7.6 (SD 3.9) …
Footnotes
-
Proprietary interest: none.